Athira Pharma to Participate in Upcoming June Conferences
31 Maio 2023 - 8:00AM
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage
biopharmaceutical company focused on developing small molecules to
restore neuronal health and slow neurodegeneration, today announced
that Company management will participate in the following upcoming
investor conferences:
Jefferies Healthcare ConferenceFireside Chat on
Wednesday, June 7, 2023, at 8:30 a.m. ET in New York
Goldman Sachs 44th
Annual Global Healthcare ConferencePresentation on
Wednesday, June 14, 2023, at 8:40 a.m.PT in Dana Point,
California
Live webcasts of the Jefferies fireside chat and Goldman Sachs
presentation can be accessed from the Investors section of the
Athira website at
https://investors.athira.com/news-and-events/events-and-presentations-investor.
An archived replay of the webcasts will be available for at least
30 days following the event.
About Athira Pharma, Inc.Athira Pharma, Inc.,
headquartered in the Seattle, Washington area, is a late
clinical-stage biopharmaceutical company focused on developing
small molecules to restore neuronal health and slow
neurodegeneration. Athira aims to provide rapid cognitive
improvement and alter the course of neurological diseases with its
novel mechanism of action. Athira is currently advancing its
pipeline of therapeutic candidates targeting the HGF/MET
neurotrophic system for Alzheimer’s and Parkinson’s disease,
Dementia with Lewy bodies and amyotrophic lateral sclerosis (ALS).
For more information, visit www.athira.com. You can also follow
Athira on Facebook, LinkedIn, Twitter and @athirapharma on
Instagram.
Investor & Media Contact:
Julie RathbunAthira
PharmaJulie.rathbun@athira.com206-769-9219
Athira Pharma (NASDAQ:ATHA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Athira Pharma (NASDAQ:ATHA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024